chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Dyspnoea, Fatigue, Hypoaesthesia, Joint swelling
Clinical narrative: Extreme fatigued; Swollen, swelling joints; extreme joint pain; Could not catch breathe had to sit down,; Numbness in Left arm and joints; Face broke out and skin went from dry to oily; Called in Sick; This is a spontaneous report from a contactable consumer. A 37-year-old non-pregnant female patient received an unknown dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: eng205) via an unspecified route of administration in the left arm on 06Mar2021 (at the age of 37-years-old) as a single dose for COVID-19 immunisation. The patient had a history of seasonal allergies and sensitive to medication in the past. The concomitant medication included RITUAL, MEGARED, RITUAL VITAMIN, Burpropion HCL 150 mg (MANUFACTURER UNKNOWN), MOVE FREE JOINT HEALTH, ALLERTEC, magnesium 400mg (MANUFACTURER UNKNOWN), VITAMIN E, EVENING PRIMROSE and IMMUNITY BOOST for an unknown indication. The patient did not receive any other vaccines within 4 weeks prior to the COVID-19 vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 08Mar2021 (Within 72 hours), the patient experienced extreme fatigued, swollen, extreme joint pain, couldn't catch breathe had to sit down, called in sick, still struggling with swelling numbness in left arm and joints, face broke out and skin went from dry to oily. No therapeutic measures were taken for the reported events. The events had not resulted in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of fatigue, joint swelling, joint pain, numbness, oily face, feeling sick and breathlessness were recovered with sequelae on an unknown date of Mar2021.   No follow-up attempts are needed. No further information is expected.
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Malaise, Seborrhoea
Clinical narrative: Extreme fatigued; Swollen, swelling joints; extreme joint pain; Could not catch breathe had to sit down,; Numbness in Left arm and joints; Face broke out and skin went from dry to oily; Called in Sick; This is a spontaneous report from a contactable consumer. A 37-year-old non-pregnant female patient received an unknown dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: eng205) via an unspecified route of administration in the left arm on 06Mar2021 (at the age of 37-years-old) as a single dose for COVID-19 immunisation. The patient had a history of seasonal allergies and sensitive to medication in the past. The concomitant medication included RITUAL, MEGARED, RITUAL VITAMIN, Burpropion HCL 150 mg (MANUFACTURER UNKNOWN), MOVE FREE JOINT HEALTH, ALLERTEC, magnesium 400mg (MANUFACTURER UNKNOWN), VITAMIN E, EVENING PRIMROSE and IMMUNITY BOOST for an unknown indication. The patient did not receive any other vaccines within 4 weeks prior to the COVID-19 vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 08Mar2021 (Within 72 hours), the patient experienced extreme fatigued, swollen, extreme joint pain, couldn't catch breathe had to sit down, called in sick, still struggling with swelling numbness in left arm and joints, face broke out and skin went from dry to oily. No therapeutic measures were taken for the reported events. The events had not resulted in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of fatigue, joint swelling, joint pain, numbness, oily face, feeling sick and breathlessness were recovered with sequelae on an unknown date of Mar2021.   No follow-up attempts are needed. No further information is expected.
Sex: M
Vaccine: COVID19
Symptoms: Chest pain, Hypoaesthesia
Clinical narrative: minor left chest pain, slight numbness in left wrist and hand; slight numbness in left wrist and hand; This is a spontaneous report from a contactable consumer, the patient. A male patient of unspecified age received his unspecified dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: 9266), via an unspecified route of administration in the left arm on 18Mar2021 at 14:30 as a single dose for COVID-19 immunisation. The patient medical history diabetes, pancreatitis, heart problems (heart disorder) since unknown date. Prior to vaccination, the patient did not diagnose with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. The patient did not have allergies to medications, food, or other products. The patient did not receive any other vaccines within for weeks prior to the COVID-19 vaccine. Concomitant medications included creon (MANUFACTURER UNKNOWN), simvastatin (MANUFACTURER UNKNOWN), losartan (MANUFACTURER UNKNOWN), metformin (MANUFACTURER UNKNOWN) started on unknown date within 2 weeks of vaccination and unknown if ongoing. The patient experienced minor left chest pain, slight numbness in left wrist and hand on 19Mar2021 at 10:00. The outcome of the events minor left chest pain, slight numbness in left wrist and hand were not recovered at the time of reporting.   No follow-up attempts are needed. No further information is expected.
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Bone pain, Heart rate, Heart rate abnormal, Pyrexia
Clinical narrative: Bone pain in the pelvis and hips; Resting heart rate between 135-145 bpm for ten hours; Fever of 101 degrees; This is a spontaneous report received from a non-contactable consumer, the patient. A 46-year-old non pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EP7534), via an unspecified route of administration in the left arm on 13Mar2021 at 11:30 (at the age of 46-years-old) as single dose for COVID-19 immunisation. Medical history included acute myeloid leukaemia (AML), stem cell transplant, graft versus host disease (GVHD), Graves' disease and COVID-19. Prior to vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19.  Concomitant medications included sirolimus (MANUFACTURER UNKNOWN), sulfamethoxazole; trimethoprim (BACTRIM DS), valaciclovir (VALTREX) and levothyroxine (MANUFACTURER UNKNOWN) taken for unknown indications from unspecified dates. The patient previously received penicillin (MANUFACTURER UNKNOWN), levofloxacin (LEVOQUIN), and vancomycin (MANUFACTURER UNKNOWN) and experienced drug allergy. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. On 14Mar2021 at 01:30, 14 hours after the vaccination the patient experienced significant bone pain in the pelvis and hips which caused a resting heart rate between 135 to 145 beats per minute (BPM) for ten hours due to pain and fever of 101 degrees. The adverse event did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care.  Therapeutic measures included intake of paracetamol (TYLENOL) during the same time frame. The patient did not receive any treatment for the event resting heart rate between 135 to 145 beats per minute (BPM). The clinical outcomes of the events bone pain in the pelvis and hips, heart rate between 135 to 145 BPM for ten hours and fever of 101 degrees were recovered on unspecified date in Mar2021.   No follow-up attempts are needed. No further information is expected.
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Malaise, Nausea, Pain
Clinical narrative: all-over body aches; chills; nausea; fatigue; general malaise; injection site is achy; This is a spontaneous report received from a contactable patient. A 59-year-old female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6202, via an unspecified route of administration in the left arm on 18Mar2021 at 13:00 (at the age of 59-years-old) as a single dose for COVID-19 immunisation. The patient medical history included arthritis, fibromyalgia, kidney disease, high blood pressure and mild asthma. The patient previously received ampicillin and vancomycin and experienced allergy. Concomitant medications included blood pressure and depression medications (unspecified). Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. On 19Mar2021 at 02:30, the patient experienced all-over body aches, chills, nausea, fatigue, general malaise and vaccination site pain. The patient was treated with pain medications (unspecified) and resting. The adverse event did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of all-over body aches, chills, nausea, fatigue, general malaise and vaccination site pain was not recovered.   No follow-up attempts are needed. No further information is expected.
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: all-over body aches; chills; nausea; fatigue; general malaise; injection site is achy; This is a spontaneous report received from a contactable patient. A 59-year-old female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6202, via an unspecified route of administration in the left arm on 18Mar2021 at 13:00 (at the age of 59-years-old) as a single dose for COVID-19 immunisation. The patient medical history included arthritis, fibromyalgia, kidney disease, high blood pressure and mild asthma. The patient previously received ampicillin and vancomycin and experienced allergy. Concomitant medications included blood pressure and depression medications (unspecified). Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. On 19Mar2021 at 02:30, the patient experienced all-over body aches, chills, nausea, fatigue, general malaise and vaccination site pain. The patient was treated with pain medications (unspecified) and resting. The adverse event did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of all-over body aches, chills, nausea, fatigue, general malaise and vaccination site pain was not recovered.   No follow-up attempts are needed. No further information is expected.
Age: 33.0
Sex: M
Vaccine: COVID19
Symptoms: Headache, SARS-CoV-2 test
Clinical narrative: headache during the whole night and next day; This is a spontaneous report received from a consumer. A 33 years old male patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number EN6202) via an unspecified route of administration in the right arm on 01Mar2021 at 15:00 (at the age of 33 years old) as a single dose for COVID-19 immunisation. Medical history was not reported.  No concomitant medications were reported. The Patient did not have any allergies to medications, food, or other products. The patient had not received any other vaccines within 4 weeks prior to the COVID vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had been tested positive for COVID-19. On 01Mar2021 at 19:00, the patient experienced headaches about every three days, the headache starts at night and is present during the whole night and the next day. The patient underwent nasal swab on 25Sep2020 and resulted negative and nasal swab on 04Dec2020 and resulted negative and Nucleic acid amplification PCR and TMA, Nasal swab on 11Nov2020 and resulted negative and nasal swab on 10Feb2021 and resulted negative and Nucleic acid amplification PCR and TMA, Nasal swab on 26Feb2021 and  resulted negative. The patient did not receive any treatment for the events. The clinical outcome of the headache was not recovered.   No follow-up attempts are possible. No further information is expected.
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain, Intermenstrual bleeding
Clinical narrative: Irregular Vaginal Bleeding, Post PeriodAbdominal Cramps ever since after shot; Post Period Abdominal Cramps; This is a spontaneous report received from a contactable consumer, the patient. A 36-year-old non pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE; Lot number: EN6199) via an unspecified route of administration in left arm on 10Mar2021 at 16:15 (at the age of 36 years old) as a single dose for COVID-19 immunisation. The patients medical history included COVID-19 and no concomitant medications were reported. The patient previously took flagyl for unknown indication and experienced the allergy. The patient had not received any other vaccines within 4 weeks prior to the COVID vaccine. Patient had not tested positive for COVID-19 since the vaccination. On 12Mar2021, the patient experienced Irregular vaginal bleeding, post period abdominal cramps ever since after shot. The patient did not receive treatment for the reported event. The clinical outcome of the event intermenstrual bleeding and abdominal cramps was not recovered.   No follow-up attempts are possible. No further information is expected.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Burning mouth syndrome
Clinical narrative: Burning mouth syndrome for 3 weeks; This is a spontaneous report from a contactable nurse, the patient. A 62-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; lot number: EN6203) via an unspecified route of administration in the left arm on 26Feb2021 at 10:30 (at the age of 62-years-old) as a single dose for COVID-19 immunisation. The medical history included cardiac surgery, abd surgery, depression, anxiety and memory impairment. The patient had a history of allergy to Zyban and Levaquin drugs. The concomitant medications included nifedipine (MANUFACTURER UNKNOWN), duloxetine (MANUFACTURER UNKNOWN), Vit B12, Fish Oil for an unknown indication. The patient did not receive any vaccination within four weeks prior to the COVID-19 vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 28Feb2021, the patient experienced burning mouth syndrome for 3 weeks. No therapeutic measures were taken for the reported events. The events had not resulted in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the burning mouth syndrome was resolving at the time of this report.   No follow-up attempts are needed. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Abdominal discomfort, Arthralgia, Chills, Headache, Nausea
Clinical narrative: Fever; chills; headache; nausea; stomach irritation; throat irritation; shoulder pain; This is a spontaneous report received from a contactable consumer from a Pfizer sponsored program. A female patient of an unspecified age received second dose of BNT162B2 (Pfizer COVID-19 Vaccine: Solution for injection; Batch/Lot number: unknown), dose 2 via an unspecified route of administration on 12Mar2021 as DOSE 2, SINGLE for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient received first dose of BNT162B2 on an unspecified date for covid-19 immunisation. On an unspecified date patient had experienced fever, chills, headache, nausea, stomach and throat irritation and shoulder pain. The outcome of the events was unknown.  Information on the lot/batch number has been requested.  Follow-up attempts completed. No further information expected.
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, Throat irritation
Clinical narrative: Fever; chills; headache; nausea; stomach irritation; throat irritation; shoulder pain; This is a spontaneous report received from a contactable consumer from a Pfizer sponsored program. A female patient of an unspecified age received second dose of BNT162B2 (Pfizer COVID-19 Vaccine: Solution for injection; Batch/Lot number: unknown), dose 2 via an unspecified route of administration on 12Mar2021 as DOSE 2, SINGLE for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient received first dose of BNT162B2 on an unspecified date for covid-19 immunisation. On an unspecified date patient had experienced fever, chills, headache, nausea, stomach and throat irritation and shoulder pain. The outcome of the events was unknown.  Information on the lot/batch number has been requested.  Follow-up attempts completed. No further information expected.
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Hypoaesthesia
Clinical narrative: Numbness around the lips and the chin area; This is a spontaneous report received from a contactable consumer, the patient. A 64-year-old non-pregnant female patient received  BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6208) via an unspecified route of administration on 17Mar2021 at 10:00 (at the age of 64-year-old) as a single dose for COVID-19 immunisation. Medical history included mild asthma (currently no treatment), chronic bronchitis (lifelong, prior to giving up cow's milk 15+ years ago- no problem since). Concomitant medications included XYZAL, EXEDRIN, BENADRYL, Probiotics(MANUFACTURER UNKNOWN) and triphala(MANUFACTURER UNKNOWN). Any allergies to medications, food, or other products were reorted to cow's milk (not an anaphylactic reaction),  some fragrances (asthma) and insect bites (excessive itching and swelling compared to others). The patient did not receive any other vaccines within 4 weeks prior to COVID vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested positive for COVID-19. On 17Mar2021 at 10:45, the patient experienced numbness around the lips and the chin area, similar to the feeling when numbed at the dentist, but it had almost worn off. There did not seem to be any swelling. The tongue might have been affected, but less than the lips. The patient did not receive any treatment for the event. The clinical outcome of event numbness was recovering.   No follow-up attempts are needed. No further information is expected.
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Peripheral swelling, Viral test
Clinical narrative: Swelling and pain under the arms; Swelling and pain under the arms; This is a spontaneous report from a contactable consumer, the patient. A 60-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN), via an unspecified route of administration in the left arm on 02Mar2021 at 8:45 as a single dose for COVID-19 immunisation. Medical history included thyroid. Concomitant medications taken within two weeks of vaccination included levothyroxine (MANUFACTURER UNKNOWN), vitamin D3 (MANUFACTURER UNKNOWN), metoprolol ER succinate (MANUFACTURER UNKNOWN). The patient had a history of drug allergy to hydrocodeine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 24Feb2021, the patient underwent lab test included a nasal swab and the result was negative. On 02Mar2021, the patient developed swelling and pain under the arms. No treatment was received for the events. The clinical outcome of the events swelling and pain under the arms was resolved on an unknown date.   Information about lot number cannot be obtained. No further information is expected.
Sex: U
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: Mild pain/soreness at the injection site; This is spontaneous report from a non-contactable consumer, the patient. An adult patient of unknown age and gender received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6203), via an unspecified route of administration on an unknown date, as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient experienced mild pain/soreness at the injection site on 18Mar2021. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. No treatment was taken as a result of mild pain/soreness at the injection site. The clinical outcome of mild pain/soreness at the injection site was unknown at the time of this report.   No follow-up attempts are possible. No further information is expected.
Age: 81.0
Sex: M
Vaccine: COVID19
Symptoms: Dizziness
Clinical narrative: Severe dizziness; This is a spontaneous report received from a contactable consumer, the patient. An 81-year-old male patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot no: UNKNOWN), via an unspecified route of administration in the left arm on 16Mar2021 at 14:00 (at the age of 81-years-old), as a single dose for COVID-19 immunisation. Patient did not have known allergy and did not have any other relevant medical hisotry. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot no: UNKNOWN), via an unspecified route of administration in the left arm on 23Feb2021 at 16:00, as a single dose for COVID-19 immunisation. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the vaccine. The patient did not receive any other medications within two weeks of vaccination. On 19Mar2021 at 02:00, the patient experienced severe dizziness on awakening. The patient did not receive any treatment for events. The adverse events didn't result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of severe dizziness was resolving at the time of reporting.   Information about lot/batch number cannot be obtained. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Illness, Pain
Clinical narrative: Aches; Fatigue; ILL; This is a spontaneous report from the contactable consumer (patient) in response to Non-HCP let-ter. A 77-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Batch/lot number: EL3244 and Expiration date: unknown) via unspecified route of administration on 15Feb2021 as 2nd dose, single dose for Covid-19 immunisation. Medical history included covid-19 from 08Nov2020 to an unknown date, ongoing arthritis (arthritis pain was still an issue). Concomitant medications was not reported. It took about 5 weeks to get over it, especially the physical and mental fatigue when patient experienced Covid-19 earlier on 08Nov2020. Patient took 1st dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Batch/lot number: EL3248) via unspecified route of administration on 28Jan2021, and the day after first shot developed chills, fever, fatigue, and greatly increased arthritis pain. After second dose of vaccination, she was quite ill the following day and laid around with aches and fatigue. As of 09Mar2021, patient had gotten better. She had her stamina back and was able to walk and exercise as before. However arthritis pain was still an issue. Her hands were previously not good, but knees, that were ok except for an occasional twinge hurt all of the time. Patient was wearing knee stabilizer to lessen the wear and tear. The outcome of events was recovering.  No follow up attempts are possible. No further information is expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021092526 same reporter, patient/different drug and event
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Diarrhoea, Fatigue, Headache, Hyperhidrosis, Myalgia
Clinical narrative: Uncontrollable diarrhea; Fatigue; Muscle soreness  all over body; Sweating; Headache; This is a spontaneous report from a contactable consumer, the patient. A 34 years old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: EN6207), via an unspecified route of administration in the right arm on 18Mar2021 at 18:45 (at the age of 34-year-old), as a single dose for COVID-19 immunisation. The patient medical history included type 2 diabetes. The patient did not have allergies to medications, food, or other products. Concomitant medications included Vitamin D2 (MANUFACTURER UNKNOWN), blisovi 24 Fe (MANUFACTURER UNKNOWN) for an unknown indication from an unspecified date. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient was not tested for COVID-19. On 19Mar2021 at 10:00, the patient experienced uncontrollable diarrhoea, fatigue, muscle soreness all over body, sweating and headache. The patient did not receive any treatment for adverse event. The clinical outcome of uncontrollable diarrhoea, fatigue, muscle soreness all over body, sweating and headache was not resolved at the time of this report.   No follow-up attempts are needed. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Joint stiffness, Pain
Clinical narrative: Fatigue; Stiff joints; achiness; This is a spontaneous report from a contactable consumer or other non-health care professional. A 51-years-old female patient received second dose of bnt162b2 (PFIZER BIONTECH COVID-19 VACCINE, solution for injection, Lot number was not reported) via an unspecified route of administration, administered in arm left on an unspecified date as dose 2, single for COVID-19 immunization. Medical history included root canal, dental pain from 06Jan2021 to 06Jan2021. Concomitant medications included azithromycin (AZITHROMYCIN) from 06Jan2021 to 10Jan2021. Vaccine administration at Military Facility. The patient was not been visit emergency room, physician room. The patient previously took BNT162B2, dose 1 single, for COVID-19 immunization. The patient experienced fatigue, stiff joints, achiness after 2nd dose for 3 days 12Jan-14 all day. For 2nd dose of COVID Vaccine, patient felt quite fatigued for 3 days. She missed work 2 days dur to extreme fatigue for 2nd Vaccine. The outcome of event was unknown.  No follow-up attempts are possible. Information about Lot/Batch number cannot be obtained.
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Diarrhoea, Pain in extremity
Clinical narrative: Chills; Diarrhea; Very sore arm; This is a spontaneous report received from a contactable consumer, the patient. A 32-years-old non-pregnant female patient received her first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: En6204) via an unspecified route of administration in left arm on 18Mar2021 at 12:30 (at the age of 32-years-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. The patient had not received any other vaccines within 4 weeks prior to COVID-19 vaccine. Prior to the vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested positive for COVID-19. On 18Mar2021 at 20:00 the patient experienced chills, diarrhoea, and very sore arm. No treatment was received for the events. The clinical outcome of the events chills, diarrhoea, and very sore arm was unknown at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 65.0
Sex: M
Vaccine: COVID19
Symptoms: Lacrimation increased, Pruritus
Clinical narrative: This is a spontaneous report from a contactable consumer, patient. A 65-year-old male patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: En6198) via an unspecified route of administration on 02Mar2021 (at the age of 65-year-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Patient had no known allergies to medications, food or other products. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient received other unspecified medications within 2 weeks of vaccination. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19.The patient experienced itchy arm, itchy and watery eye on an unknown date in Mar2021.The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for itchy arm and watery eye. The clinical outcome of itchy and watery eye was recovered on an unknown date in Mar2021. No follow-up attempts are needed. No further information is expected.
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Gait inability, Vomiting
Clinical narrative: Dizziness; vomiting, unable to move; unable to move; This is a spontaneous report from a contactable consumer, the patient. . A 60-year-old non pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot no: unknown) via an unspecified route of administration in the right arm on 13Mar2021 at 18:15 (at the age of 60-years-old) as a single dose for Covid-19 immunisation. Medical history and concomitant medications were not reported. The Patient did not have any allergies to medications, food, or other products. The patient was not diagnosed with COVID-19 prior to vaccination. The patient had not tested positive for COVID-19 since the vaccination. The patient experienced Dizziness, vomiting and unable to move on unknown date (reported date 12Mar2021 at 09:15). It was unknown if patient received treatment for the events. The clinical outcome of the Dizziness, vomiting and unable to walk was not recovered.   Information about lot number cannot be obtained. No further information expected
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: Sore arm; This is a spontaneous report received from a contactable consumer, the patient. A 53-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot no: EL3247) via an unspecified route of administration in the left arm on 18Mar2021 at 10:45 (at the age of 53-years-old) as a single dose for COVID-19 immunisation. Medical history included hypothyroid, gastrointestinal stromal tumour (GIST) and allergy to penicillin. The patient had taken unspecified concomitant medications within 2 weeks of vaccination. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot no: EL3247) via an unspecified route of administration in the right arm on 25Feb2021 at 10:30 as a single dose for COVID-19 immunisation. The patient had not received any other vaccines within four weeks prior to the vaccination. On 19Mar2021, at 05:00, the patient experienced sore arm. The patient did not receive any treatment for the event sore arm. The adverse event did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of event sore arm was reported as recovering at the time of this report.   No follow-up attempts are possible. No further information is expected.
Age: 70.0
Sex: M
Vaccine: COVID19
Symptoms: Paraesthesia oral, Pruritus
Clinical narrative: Tingling in lips; Felt a bit itchy; This is a spontaneous report received from a contactable consumer, the patient. A 70-year-old male patient received his first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: EN6207) via an unspecified route of administration in the left arm on 16Mar2021 at 10:00 (at the age of 70-years-old) as a single dose for COVID-19 immunisation. Medical history included prostate cancer and high blood pressure (HBP). Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. Concomitant medications included amlodipine (MANUFACTURER UNKNOWN), hydrochlorothiazide (HCTZ) (MANUFACTURER UNKNOWN), aspirin 81 mg (MANUFACTURER UNKNOWN) and tamsulosin (MANUFACTURER UNKNOWN), all for unknown indications on unknown dates. The patient's past drug history included allergic to sulfa. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. On 16Mar2021 at 10:00, the patient experienced some tingling in lips and felt a bit itchy. The adverse event did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the events tingling in lips and felt a bit itchy. The clinical outcomes of the events tingling in lips and felt a bit itchy were recovered on an unknown date in Mar2021.   No follow-up attempts are needed. No further information is expected.
Age: 23.0
Sex: M
Vaccine: COVID19
Symptoms: Dyspnoea, Heart rate increased, Nausea
Clinical narrative: This is a spontaneous report received from a contactable consumer, the patient. A 23-year-old male patient received his first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EP6955) via an unspecified route of administration in the left arm on 19Mar2021 at 08:45 (at the age of 23-years-old), as a single dose for COVID-19 immunisation. Medical history was not reported. The patient did not had any allergies to food, medications, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Since the vaccination, the patient had not been tested positive for COVID-19. The patient did not receive any other medications within 2 weeks of vaccination. On 19Mar2021 at 13:00, the patient experienced fast heartbeat, slight shortness of breath and nausea. The patient did not receive any treatment for the reported events. The adverse event did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events fast heartbeat, slight shortness of breath and nausea was not recovered at the time of this report. No follow-up attempts are needed. No further information is expected.
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Pain in extremity, Pyrexia, Rash
Clinical narrative: Very sore arm; rash on my thigh that was also tender; fever of 102.4; This is a spontaneous report from a contactable consumer, the patient. A 71-year-old non - pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6201) via an unspecified route of administration in the left arm on 10Mar2021 at 07:30 (at the age of 71-years- old) as a single dose for COVID-19 immunisation. The patient medical history was reported as immunocompromised, COPD, Rheumatoid arthritis (RA) and osteoporosis. The patient had allergies to ceclor and iodine. Concomitant medications included methotrexate (MANUFACTURER UNKNOWN), CELEBREX , vitamins (MANUFACTURER UNKNOWN), folic acid (MANUFACTURER UNKNOWN), calcium (MANUFACTURER UNKNOWN) for unknown indication from unknown date . Prior to the vaccination, the patient was not test positive for COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 17Mar2021, the patient experienced very sore arm, painful rash and  fever of 102.4. It was reported that Firstly, the patient was immunocompromised and other than a very sore arm she had no other event until a week later. Then she developed a rash on her thigh that was also tender and a fever of 102.4. By the next day the fever was down to normal but the rash and tenderness remain.  The patient did not receive any treatment for the events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events sore arm, painful rash and fever was recovering at the time of report.   No follow-up attempts are needed. No further information is expected.
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site warmth
Clinical narrative: Red knot on vaccine site (4cm diameter); Warm to touch; This is a spontaneous report from a contactable consumer, the patient. A 39-year-old non-pregnant female patient received her first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6207) via unspecified route of administration in left arm on 10Mar2021 at 16:45 (at the age of 39-years-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. The patient possibly allergic to penicillin and onion food intolerance. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested positive for COVID-19. It was reported that the patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 19Mar2021 at 14:30, the patient experienced red knot on vaccine site (4 cm diameter), warm to touch. The patient did not receive treatment for the events. The clinical outcome of red knot on vaccine site (4cm diameter), warm to touch were not recovered.  No follow-up attempts are needed. No further information is expected
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Thirst, Vertigo
Clinical narrative: Vertigo; Very thirsty; Tired; This is a spontaneous report received from a contactable consumer, the patient. A 69-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6205) via an unspecified route of administration and anatomical site on 05Mar2021 at 12:15 (at the age of 69-years-old), as single dose for COVID-19 immunisation. The patient medical history included benign paroxysmal positional vertigo (BPPV), Persistent Postural-Perceptual Dizziness (3PD) and osteoporosis. The patient had no allergies. The patient did not receive any other vaccines within four weeks prior to the vaccination. Past drug history included first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6201) via an unspecified route of administration in the left arm on 12Feb2021 at 12:15 (at the age of 69-year-old), as single dose for COVID-19 immunisation. Concomitant medications included loratadine 10 mg (MANUFACTURER UNKNOWN) and vitamin D 2000 IU (MANUFACTURER UNKNOWN). Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 06Mar2021 at 06:00, the patient woke up with intense vertigo and could not raise her head without the sensation of spinning. Her husband had to help her to the bathroom, then to a chair. It was reported that the spinning stopped but it would start again if patient move her head left or right. The patient was very thirsty. It decreased over 2 hours, and then she was just a little tired. The patient received treatment for the events. The clinical outcome of event vertigo was resolved in Mar2021, very thirsty was resolving and for tired was unknown. No follow-up attempts are possible. No further information is expected.
Age: 51.0
Sex: M
Vaccine: COVID19
Symptoms: Hypoaesthesia, Neck pain
Clinical narrative: left face numbness; moderate pain up the left side of neck 8 hours after injection,; This is a spontaneous report received from a contactable consumer, the patient. A 51-year-old male patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6207) via unspecified route of administration on right arm on 18Mar2021 at 09:45 (at the age of 51 year) as a single dose for COVID-19 immunisation. Past medical history included penicillin allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not tested for COVID-19. Concomitant medication included olmesartan (MANUFACTURER UNKNOWN) from an unspecified date for an unknown indication and CENTRUM MEN 50+ MULTIVITAMIN from an unspecified date for an unknown indication. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 18Mar2021 at 17:45 the patient experienced moderate pain up the left side of neck. On 18Mar2021 at 21:45 the patient experience face numbness. The patient visited doctor or other healthcare professional office/clinic visit, Emergency room/department or urgent care visit for the event occurred. No no treatment was taken in response to the event. It was reported that on the day of vaccination, the patient experienced moderate pain up the left side of neck, the patient took a nap and woke with left face numbness approximately 12 hours after the injection. the patient. The clinical outcome of the event neck pain and facial numbness was not recovered. No follow-up attempts are needed. No further information is expected
Age: 26.0
Sex: F
Vaccine: COVID19
Symptoms: Myalgia
Clinical narrative: Sharp and burning  on the right buttock muscle; This is a spontaneous report received from a contactable patient. A 26-year-old female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: Unknown) via unspecified route of administration in left arm on an 18Mar2021 at 03:00 pm (at 26 years of age) as a single dose for COVID-19 immunisation. The patients medical history stated suspected COVID-19 and no concomitant medication was reported. No allergies to medications, food, or other products were reported. The patient did not have any symptoms associated with COVID-19 prior to vaccination. The patient had not tested positive for COVID-19 since having the vaccine. On 18Mar2021 at 03:30 pm, the patient experienced severe sharp and burning on the right buttock muscle. The patient did not receive any treatment for the adverse event. The event resulted in doctor or other healthcare professional office/clinic visit. The clinical outcome of the event severe sharp and burning on the right buttock muscle was not recovered at the time of the report.    Information about lot/batch number cannot be obtained. No further information is expected.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Pruritus
Clinical narrative: Started with redness on left side of chin on Thursday morning spread to right side and spread up to cheeks and down to chest. It became very itchy.; Started with redness on left side of chin on Thursday morning spread to right side and spread up to cheeks and down to chest. It became very itchy.; This is a spontaneous report from a contactable consumer, the patient. A 62-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER- BIONTECH COVID-19 mRNA Vaccine, Lot number: En6208) via an unspecified route of administration in the left arm on 15Mar2021 at 11:00 (at the age of 62-years-old) as a single dose for COVID-19 immunisation. The patient's medical history included cancer of the mouth. Concomitant medications included ibuprofen (MANUFACTURER UNKNOWN), nortriptyline (MANUFACTURER UNKNOWN) and lorazepam (MANUFACTURER UNKNOWN) all for unknown indication. The patient previously received levofloxacin hemihydrate and experienced allergy. The patient also previously received the first dose of BNT162b2 (PFIZER- BIONTECH COVID-19 mRNA Vaccine, Lot number: EN9809) via an unspecified route of administration in the left arm on 22Feb2021 at 11:00, as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within 4 weeks prior to the COVID-19 vaccine. The patient was not diagnosed with COVID-19 prior to the vaccination. Since the vaccination, the patient was not tested for COVID-19. On 18Mar2021 at 12:00, the patient experienced redness on the left side of the chin and on the same day morning it had spread to right side and spread up to cheeks and down to the chest. It was very itchy too. The adverse event resulted in an emergency room/ department visit or urgent care. The patient was treated with hydroxyzine hydrochloride tablet (MANUFACTURER UNKNOWN) and triamcinolone acetone (MANUFACTURER UNKNOWN) for the reported events. The clinical outcome of the events redness and itchy was recovering at the time of the report.   No follow-up attempts are needed. No further information is expected.
Age: 59.0
Sex: M
Vaccine: COVID19
Symptoms: Vitreous floaters
Clinical narrative: Eye floaters; This is a spontaneous report received from a contactable consumer, the patient. A 59-year-old male patient received his first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EW6199) via an unspecified route of administration in the left arm on 04Mar2021 at 17:00 (at the age of 59-year-old) as single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. The patient did not have any allergies to medications, food, or other products. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 08Mar2021, the patient experienced eye floaters. The patient did not receive any treatment for the event. The clinical outcome of the event eye floaters was not resolved at the time of this report. No follow-up attempts are needed. No further information is expected.
Age: 0.17
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Chills, Fatigue, Nasopharyngitis, Pain
Clinical narrative: very cold; fatigue; body aches; Severe tremors and shaking lasting one and a half hour.; Chills; fever of 102.1; This is a spontaneous report received from a contactable consumer, the patient. A 74-year-old non-pregnant female received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE; Lot number: EN6200, via unspecified route of administration in the right arm on an 19Feb2021 at 18:00 (at the age of 74-years-old) as a single dose for COVID-19 immunisation. The patients past medical history was not provided. The concomitant medications included amlodipine (MANUFACTURER UNKNOWN), losartan (MANUFACTURER UNKNOWN), esomeprazole (MANUFACTURER UNKNOWN) and magnesium (MANUFACTURER UNKNOWN). The patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE; Lot number: EP7534), via unspecified route of administration in right arm on an 14Mar2021 at 11:30 as a single dose for COVID-19 immunisation. The patient was not diagnosed with COVID-19 prior to vaccination and was not tested for COVID-19 since having the vaccine. The patient had not received any other vaccines within 4 weeks prior to the COVID vaccine. On 15Mar2021 at 12:30, the patient experienced severe tremors and shaking which lasted for one and a half hour. After that, chills and fever of 102.1. On 16Mar2021, the following day, the patient felt very cold, experienced fatigue and some body aches. No treatment was received for these events and the events had not resulted in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events tremors, chills, fever, cold, fatigue and body aches were recovered on an unspecified date.   No follow-up attempts are possible. No further information is expected.